<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01644357</url>
  </required_header>
  <id_info>
    <org_study_id>ATENFAR-PROAR</org_study_id>
    <nct_id>NCT01644357</nct_id>
  </id_info>
  <brief_title>Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma</brief_title>
  <official_title>PROJECT IMPLEMENTATION OF PHARMACEUTICAL CARE IN SEVERE ASTHMA IN OUTPATIENT PHARMACY DEPARTMENT.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Bahia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Bahia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Only a few well-designed studies have investigated the effect of pharmaceutical care on
      asthma patients and to date there are no published studies investigating this effect
      specifically on severe and refractory asthma.

      The objective of this study is evaluate the effect of pharmaceutical care on asthma control
      and quality of life (QoL) of patients with severe or refractory asthma compared with
      pharmacist dispensation only.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>asthma control of symptoms</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by Asthma Control Questionnaire and medical evaluation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by Asthma Quality of Life questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Lung function improvement</measure>
    <time_frame>12 months</time_frame>
    <description>Measured by spirometry</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Asthma</condition>
  <condition>Pharmacists</condition>
  <condition>Spirometry</condition>
  <condition>Quality of Life</condition>
  <condition>Pharmacy</condition>
  <arm_group>
    <arm_group_label>Dispensing only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non clinical pharmacists will dispense drugs to patients and usual care will be offered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmaceutical care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients on experimental group will receive counseling and education on the asthma condition, medication and lifestyle issues. In all visits, the inhaler technique will be reviewed, adherence to treatment and drug related problems were checked. If necessary the patient will be referred to the respiratory specialist to change the medication or to prescribe dose adjustment. Pharmacists document their initial and monthly follow up encounters using a specified form.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmaceutical care</intervention_name>
    <description>Pharmacist intervention, focused on the optimization of drug therapy, identification and resolution of drug related problems, resulting in best asthma control and quality of life. Pharmacists document their initial and monthly follow up encounters using a specified form. An action plan for self management of these patients was prepared and discussed aiming at early identification and treatment of an exacerbation episode. Meetings will be held weekly with intervention team to discuss action plan and measure of outcomes of all problems identified.</description>
    <arm_group_label>Pharmaceutical care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with severe/refractory asthma presenting other respiratory disease,

          -  ≥ 18 years of age,

          -  using high dose of inhaled corticosteroids (≥ 800mcg of budesonide or equivalent)

          -  FEV1&lt;60%,

          -  regular visitor of the pharmacy and the physicians.

        Exclusion Criteria:

          -  participation in other intervention study during this study,

          -  living in other cities,

          -  could not participate in all visits of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo M Santos, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Bahia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Álvaro A Cruz, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of Bahia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lúcia B Noblat, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Bahia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pablo M Santos, master</last_name>
    <phone>55 71 3283-8085</phone>
    <email>pablomoura@ufba.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Program for Asthma Control (ProAR) of the Federal University of Bahia</name>
      <address>
        <city>Salvador</city>
        <state>Bahia</state>
        <zip>40060-330</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Moura Santos, Pharmacist</last_name>
      <phone>55 71 3283 8085</phone>
      <email>pablomoura@ufba.br</email>
    </contact>
    <investigator>
      <last_name>Pablo Moura Santos, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2012</study_first_submitted>
  <study_first_submitted_qc>July 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2012</study_first_posted>
  <last_update_submitted>March 4, 2013</last_update_submitted>
  <last_update_submitted_qc>March 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Bahia</investigator_affiliation>
    <investigator_full_name>Pablo de Moura Santos</investigator_full_name>
    <investigator_title>Pharmacist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

